These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

934 related articles for article (PubMed ID: 31553802)

  • 1. Inhaled steroids with and without regular formoterol for asthma: serious adverse events.
    Janjua S; Schmidt S; Ferrer M; Cates CJ
    Cochrane Database Syst Rev; 2019 Sep; 9(9):CD006924. PubMed ID: 31553802
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Inhaled steroids with and without regular salmeterol for asthma: serious adverse events.
    Cates CJ; Schmidt S; Ferrer M; Sayer B; Waterson S
    Cochrane Database Syst Rev; 2018 Dec; 12(12):CD006922. PubMed ID: 30521673
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Regular treatment with formoterol and an inhaled corticosteroid versus regular treatment with salmeterol and an inhaled corticosteroid for chronic asthma: serious adverse events.
    O'Shea O; Stovold E; Cates CJ
    Cochrane Database Syst Rev; 2021 Apr; 4(4):CD007694. PubMed ID: 33852162
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Regular treatment with salmeterol and inhaled steroids for chronic asthma: serious adverse events.
    Cates CJ; Jaeschke R; Schmidt S; Ferrer M
    Cochrane Database Syst Rev; 2013 Mar; (3):CD006922. PubMed ID: 23543548
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Regular treatment with formoterol and inhaled steroids for chronic asthma: serious adverse events.
    Cates CJ; Jaeschke R; Schmidt S; Ferrer M
    Cochrane Database Syst Rev; 2013 Jun; (6):CD006924. PubMed ID: 23744625
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Regular treatment with formoterol and inhaled steroids for chronic asthma: serious adverse events.
    Cates CJ; Lasserson TJ; Jaeschke R
    Cochrane Database Syst Rev; 2009 Apr; (2):CD006924. PubMed ID: 19370661
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Combination fixed-dose beta agonist and steroid inhaler as required for adults or children with mild asthma.
    Crossingham I; Turner S; Ramakrishnan S; Fries A; Gowell M; Yasmin F; Richardson R; Webb P; O'Boyle E; Hinks TS
    Cochrane Database Syst Rev; 2021 May; 5(5):CD013518. PubMed ID: 33945639
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Safety of regular formoterol or salmeterol in adults with asthma: an overview of Cochrane reviews.
    Cates CJ; Wieland LS; Oleszczuk M; Kew KM
    Cochrane Database Syst Rev; 2014 Feb; 2014(2):CD010314. PubMed ID: 24504983
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Combination formoterol and budesonide as maintenance and reliever therapy versus current best practice (including inhaled steroid maintenance), for chronic asthma in adults and children.
    Cates CJ; Karner C
    Cochrane Database Syst Rev; 2013 Apr; 2013(4):CD007313. PubMed ID: 23633340
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Regular treatment with salmeterol and inhaled steroids for chronic asthma: serious adverse events.
    Cates CJ; Lasserson TJ; Jaeschke R
    Cochrane Database Syst Rev; 2009 Jul; (3):CD006922. PubMed ID: 19588410
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Safety of regular formoterol or salmeterol in children with asthma: an overview of Cochrane reviews.
    Cates CJ; Oleszczuk M; Stovold E; Wieland LS
    Cochrane Database Syst Rev; 2012 Oct; 10(10):CD010005. PubMed ID: 23076961
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Regular treatment with formoterol and an inhaled corticosteroid versus regular treatment with salmeterol and an inhaled corticosteroid for chronic asthma: serious adverse events.
    Cates CJ; Lasserson TJ
    Cochrane Database Syst Rev; 2010 Jan; (1):CD007694. PubMed ID: 20091646
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Combined aclidinium bromide and long-acting beta2-agonist for chronic obstructive pulmonary disease (COPD).
    Ni H; Moe S; Soe Z; Myint KT; Viswanathan KN
    Cochrane Database Syst Rev; 2018 Dec; 12(12):CD011594. PubMed ID: 30536566
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Regular treatment with formoterol and an inhaled corticosteroid versus regular treatment with salmeterol and an inhaled corticosteroid for chronic asthma: serious adverse events.
    Cates CJ; Lasserson TJ
    Sao Paulo Med J; 2010; 128(5):310-1. PubMed ID: 21181075
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Regular treatment with formoterol versus regular treatment with salmeterol for chronic asthma: serious adverse events.
    Cates CJ; Lasserson TJ
    Cochrane Database Syst Rev; 2012 Mar; 3(3):CD007695. PubMed ID: 22419326
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Addition of long-acting beta2-agonists to inhaled corticosteroids for chronic asthma in children.
    Chauhan BF; Chartrand C; Ni Chroinin M; Milan SJ; Ducharme FM
    Cochrane Database Syst Rev; 2015 Nov; 2015(11):CD007949. PubMed ID: 26594816
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Addition to inhaled corticosteroids of long-acting beta2-agonists versus anti-leukotrienes for chronic asthma.
    Chauhan BF; Ducharme FM
    Cochrane Database Syst Rev; 2014 Jan; 2014(1):CD003137. PubMed ID: 24459050
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Addition of long-acting beta2-agonists to inhaled corticosteroids versus same dose inhaled corticosteroids for chronic asthma in adults and children.
    Ducharme FM; Ni Chroinin M; Greenstone I; Lasserson TJ
    Cochrane Database Syst Rev; 2010 May; (5):CD005535. PubMed ID: 20464739
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Addition of anti-leukotriene agents to inhaled corticosteroids for adults and adolescents with persistent asthma.
    Chauhan BF; Jeyaraman MM; Singh Mann A; Lys J; Abou-Setta AM; Zarychanski R; Ducharme FM
    Cochrane Database Syst Rev; 2017 Mar; 3(3):CD010347. PubMed ID: 28301050
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Regular treatment with formoterol versus regular treatment with salmeterol for chronic asthma: serious adverse events.
    Cates CJ; Lasserson TJ
    Cochrane Database Syst Rev; 2009 Oct; (4):CD007695. PubMed ID: 19821436
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 47.